Press Releases

05-21-2026	Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
05-11-2026	Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results
05-06-2026	Pliant Therapeutics to Participate in the RBC Capital Markets Global Healthcare Conference
04-30-2026	Pliant Therapeutics Announces First Patient Dosed in FORTIFY, the Phase 1b Indication Expansion Trial Evaluating PLN-101095 in Patients with ICI-Refractory Solid Tumors
04-18-2026	Pliant Therapeutics Announces Presentation of Updated Data from the Phase 1 Trial of PLN-101095 in Patients with ICI-Refractory Solid Tumors at the 2026 AACR Annual Meeting
03-18-2026	Pliant Therapeutics Announces Upcoming Presentation of Phase 1 Clinical Trial of PLN-101095 in Patients with Solid Tumors at the 2026 AACR Annual Meeting
03-11-2026	Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2025 Financial Results
02-23-2026	Pliant Therapeutics to Participate in the Oppenheimer Healthcare Life Science Conference